Former Pfizer CEO, CFO say they will not be involved in Starboard's campaign against drugmaker
Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor Starboard Value, which reportedly wants the U.S. drug giant to make changes to turn its performance around.
Pfizer's ex-chair and chief executive Ian Read and Frank D'Amelio – previously the drugmaker's finance chief – have issued a ...
Pfizer's shares have fallen more than 9% in the past year and trade at around half of their pandemic-era highs as sales of ...
Authorizing Medicare to cover weight loss drugs would increase federal spending by about $35 billion from 2026 to 2034 ...
Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...
Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.42 fourth-quarter 2024 dividend on the ...
As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
On Tuesday, Pfizer Inc (PFE) stock saw a decline, ending the day at $29.18 which represents a decrease of $-0.02 or -0.07% from the prior close of $29.2. The stock opened at $29.21 and touched a low ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback